Cargando…

Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous

We describe a 79-year-old man with spondylodiscitis and unknown pathogen, treated with cefazolin and rifampicin. He developed a massive digestive hemorrhage. Prothrombin time was prolonged with severe vitamin-K-dependent clotting-factor deficiency. Severe bleeding can occur during cefazolin and rifa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kouki, Ines, Montagner, Clémence, Mauhin, Wladimir, London, Jonathan, Lazard, Thierry, Grimbert, Sylvie, Zeller, Valérie, Lidove, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Copernicus GmbH 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131959/ https://www.ncbi.nlm.nih.gov/pubmed/34084701 http://dx.doi.org/10.5194/jbji-6-131-2021

Ejemplares similares

Of the importance of the clinical phenotypes in the interpretation of the studies dealing with Fabry disease
por: Mauhin, Wladimir, et al.
Publicado: (2019)

Prevalence of Cancer in Acid Sphingomyelinase Deficiency
por: Mauhin, Wladimir, et al.
Publicado: (2021)

Strong increase of leukocyte apha‐galactosidase A activity in two male patients with Fabry disease following oral chaperone therapy
por: Lamari, Foudil, et al.
Publicado: (2019)

Cutibacterium acnes Prosthetic Joint Infections: Is Rifampicin-Combination Therapy Beneficial?
por: Saltiel, Grégoire, et al.
Publicado: (2022)

Acid Sphingomyelinase Deficiency: Sharing Experience of Disease Monitoring and Severity in France
por: Mauhin, Wladimir, et al.
Publicado: (2022)

Deranged Coagulation Profile Secondary to Cefazolin Use: Case Report
por: Ngiam, Jinghao Nicholas, et al.
Publicado: (2021)

No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients: Results from a retrospective controlled multicenter study
por: Burlacu, Ruxandra, et al.
Publicado: (2021)

Parsing Fabry Disease Metabolic Plasticity Using Metabolomics
por: Ducatez, Franklin, et al.
Publicado: (2021)

Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease
por: Mauhin, Wladimir, et al.
Publicado: (2020)

Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease
por: Mauhin, Wladimir, et al.
Publicado: (2022)

Multiple Resistance at No Cost: Rifampicin and Streptomycin a Dangerous Liaison in the Spread of Antibiotic Resistance
por: Durão, Paulo, et al.
Publicado: (2015)

Cefazolin Pharmacokinetics in Premature Infants
por: Balevic, Stephen J., et al.
Publicado: (2019)

Is it just a cefazolin issue?
por: Takazawa, Tomonori, et al.
Publicado: (2019)

Cefazolin and an aminoglycoside compared with cefazolin alone for the antimicrobial prophylaxis of type III open orthopedic fractures
por: Depcinski, Shawn C., et al.
Publicado: (2019)

A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry Disease
por: Tebani, Abdellah, et al.
Publicado: (2020)

Comparison the Efficacy of Cefazolin plus Gentamicin with Cefazolin plus Ciprofloxacin in Management of Type –IIIA Open Fractures
por: Janmohammadi, N, et al.
Publicado: (2011)

Cefazolin as a cause of leukocytoclastic vasculitis
por: Ali, Naveed, et al.
Publicado: (2017)

Cefazolin Plus Ceftazidime versus Cefazolin Monotherapy in the Treatment of Culture-Negative Peritonitis: A Retrospective Cohort Study
por: Kovitangkoon, Krit, et al.
Publicado: (2022)

2238. Effect of Cefazolin Breakpoint Update in Susceptibility Reports on Antimicrobial Use
por: Buckley, Valerie, et al.
Publicado: (2023)

Coagulation Parameters in Adult Patients With Type-1 Gaucher Disease
por: Serratrice, Christine, et al.
Publicado: (2019)

Serum sickness-like reaction associated with cefazolin
por: Brucculeri, Michael, et al.
Publicado: (2006)

Gelatin Methacryloyl Hydrogels for the Localized Delivery of Cefazolin
por: Vigata, Margaux, et al.
Publicado: (2021)

Streptococcal and Staphylococcus aureus prosthetic joint infections: are they really different?
por: Kherabi, Yousra, et al.
Publicado: (2022)

Pseudomonas aeruginosa prosthetic joint-infection outcomes: Prospective, observational study on 43 patients
por: Prié, Héloïse, et al.
Publicado: (2022)

Fluoroscein toxicity – Rare but dangerous
por: Juneja, Sarika, et al.
Publicado: (2019)

Rifampicin-induced disseminated intravascular coagulation in pulmonary tuberculosis treatment: A case report and literature review
por: Chen, Guo, et al.
Publicado: (2017)

2391. Liposomal Vancomycin and Cefazolin Combinations for S. aureus Biofilms
por: Kebriaei, Razieh, et al.
Publicado: (2018)

Embryo and Developmental Toxicity of Cefazolin Sodium Impurities in Zebrafish
por: Chen, Bo, et al.
Publicado: (2017)

Recovery of cefazolin and clindamycin in in vitro pediatric CPB systems
por: Zeilmaker‐Roest, Gerdien A., et al.
Publicado: (2020)

Population pharmacokinetic model of cefazolin in total hip arthroplasty
por: Lanoiselée, J., et al.
Publicado: (2021)

Prophylactic Cefazolin Dosing in Obesity—a Systematic Review
por: Coates, Matthew, et al.
Publicado: (2022)

Cefazolin access and use in Ethiopia: A policy implication
por: Alemkere, Getachew, et al.
Publicado: (2023)

2533. Cerebrospinal Fluid Penetration of Cefazolin and Flucloxacillin in Children
por: Boast, Alison, et al.
Publicado: (2023)

Randomized controlled trial of cefazolin monotherapy versus cefazolin plus azithromycin single dose prophylaxis for cesarean deliveries: A developing country's perspective
por: Jyothi, Manjeera S., et al.
Publicado: (2019)

A randomized controlled trial to compare antibiotic prophylaxis in elective gynecological surgeries: Single dose of cefazolin versus single dose of cefazolin and tinidazole
por: Garg, Shivani, et al.
Publicado: (2021)

Rifampicin-Induced Pulmonary Embolism: A Rare Side Effect
por: Alawad, Mouhammad J, et al.
Publicado: (2021)

Prophylactic cefazolin in amnioinfusions administered for meconium-stained amniotic fluid.
por: Edwards, R K, et al.
Publicado: (1999)

Isolation and Characterisation of Degradation Impurities in the Cefazolin Sodium Drug Substance
por: Sivakumar, Balasubramanian, et al.
Publicado: (2013)

Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking
por: Weiland, Ana, et al.
Publicado: (2015)

Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
por: Gern, Benjamin H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ppvupq6lc3l2n5kjnamdoin9ts